| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 994 | 16.187 | 27.148 | 29.938 | 35.408 |
| Total Income - EUR | - | - | - | - | - | 994 | 16.219 | 27.535 | 31.265 | 35.411 |
| Total Expenses - EUR | - | - | - | - | - | 141 | 5.808 | 15.854 | 19.993 | 22.019 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 853 | 10.411 | 11.681 | 11.272 | 13.392 |
| Net Profit/Loss - EUR | - | - | - | - | - | 823 | 10.233 | 11.411 | 10.966 | 12.351 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Barthadiabet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 21 | 10.772 | 7.733 | 5.562 | 2.899 |
| Current Assets | - | - | - | - | - | 1.018 | 5.428 | 12.288 | 9.198 | 11.027 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 2.713 | 8.020 | 7.568 | 7.093 |
| Cash | - | - | - | - | - | 1.018 | 2.714 | 4.269 | 1.629 | 3.933 |
| Shareholders Funds | - | - | - | - | - | 865 | 10.282 | 11.460 | 11.014 | 12.399 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 174 | 4.975 | 8.012 | 3.975 | 1.636 |
| Income in Advance | - | - | - | - | - | 0 | 1.124 | 741 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Barthadiabet S.r.l.